If you aren't a member of the American Society for Pharmacy Law, you should be, and here is one of many reasons why: dual liability for the False Claim Act and the Controlled Substances Act and Info on Oklahoma's recent court decision regarding off-label use

The Rx Ipsa Loquitur, olume 42, Number 4 July/August 2015 contains a must read article entitled, PharmMerica Settlements Highlight Potential for Dual False Claims Act and Controlled Substances Act Liability for Invalid Prescriptions written by Barbara Roland, JD, and Matt Newcomer, JD, who are Principals in the Internal Investigations and White Collar Defense Group at Post & Schell, PC's Washington D.C. and Philadelphia offices, respectively.

Members can also read about an important decision issued by an Oklahoma district court regarding off-label use which may end up being appealed and not be the final say in the case.

For information on becoming a member of the ASPL go to www.aspl.org